A 69-year-old with NSTEMI underwent PCI and is now in sinus rhythm with no AF. Two days later he develops new-onset AF with RVR (HR 140), hemodynamica...

Question

A 69-year-old with NSTEMI underwent PCI and is now in sinus rhythm with no AF. Two days later he develops new-onset AF with RVR (HR 140), hemodynamically stable. What is the preferred initial rate-control agent?

Accepted Answer

Diltiazem IV bolus/infusion

Answer

Amiodarone IV bolus as first-line

Answer

Digoxin IV as first-line

Answer

Adenosine IV

Answer

Lidocaine IV

us-abem MCQ (SBA): Atrial fibrillation-rate control

A 69-year-old with NSTEMI underwent PCI and is now in sinus rhythm with no AF. Two days later he develops new-onset AF with RVR (HR 140), hemodynamically stable. What is the preferred initial rate-control agent?